CMND
Clearmind Medicine Inc
NASDAQ · Pharmaceuticals
$1.35
-0.10 (-6.90%)
Penny Stocks
Pharmaceutical Stocks
Healthcare Stocks
Best Dividend Stocks
Highest Dividend Yield
Monthly Dividend Payers
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| EPS | — | — | — |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| Rev Growth | +19.2% | +7.8% | +18.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 383.0K | 408.4K | 345.3K |
| Total Equity | 883.2K | 914.7K | 918.2K |
| D/E Ratio | 0.43 | 0.45 | 0.38 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |